
Additional file 1: Table S1. Details about the diagnosis in the other neurodegenerative diseases (NDD) and other neurological disorders (OND) groups. Table S2. Correlations between plasma Biomarkers with Simoa and IPMS-Shim and Demographic Features. Table S3. Characteristics of Study Participants According to CSF Aβ42/40 Status and AT or AT(N) Profiles. Table S4. Correlations between Plasma Amyloid Biomarkers and CSF/Plasma Amyloid Biomarkers. Table S5. Baseline Characteristics of the 29 Individuals with follow-up and repeated biomarkers assessment. Fig. S1. Performance of the plasma amyloid biomarkers to discriminate A+T+ from A-T- subjects. ROC analysis of the amyloid biomarkers. AUC is presented with 95% confidence interval (CI).
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
